Volume 65, Issue 6, Pages (June 2004)

Slides:

Advertisements

Similar presentations

Kamyar Kalantar-Zadeh Kidney International

Advertisements

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Volume 77, Issue 12, Pages (June 2010)

Beta blockers in the management of chronic kidney disease

Michael D. Gautreaux, Barry I. Freedman Kidney International

Volume 69, Issue 11, Pages (June 2006)

S.J. Nessim, S.V. Jassal, S.V. Fung, C.T. Chan Kidney International

Paradoxical Rebound Platelet Activation After Painkillers Cessation: Missing Risk for Vascular Events? Victor L. Serebruany, MD, Alex I. Malinin, MD,

Anemia management in chronic kidney disease

Volume 84, Issue 1, Pages (July 2013)

Reassessment of the care of the patient with chronic kidney disease

Volume 74, Issue 5, Pages (September 2008)

C-reactive protein and dialysis access

Volume 75, Issue 11, Pages (June 2009)

Volume 54, Issue 2, Pages (August 1998)

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Volume 57, Pages S74-S81 (January 2000)

Kamyar Kalantar-Zadeh Kidney International

The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age B.O. Eriksen, O.C. Ingebretsen Kidney International

Medical management of osteoarthritis

Volume 84, Issue 1, Pages (July 2013)

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 61, Issue 6, Pages (June 2002)

S.J. Nessim, S.V. Jassal, S.V. Fung, C.T. Chan Kidney International

Volume 71, Issue 11, Pages (June 2007)

Nephrology Crosswords: Hemodialysis

Volume 69, Issue 2, Pages (January 2006)

Edmund G. Lowrie Kidney International

Volume 62, Issue 6, Pages (December 2002)

Gentamicin pharmacokinetics during slow daily home hemodialysis

Volume 64, Issue 5, Pages (November 2003)

Volume 75, Issue 1, Pages (January 2009)

Blood pressure targets in hemodialysis patients

Volume 65, Issue 6, Pages (June 2004)

Volume 75, Issue 11, Pages (June 2009)

Volume 66, Issue 5, Pages (November 2004)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 70, Issue 10, Pages (November 2006)

Volume 64, Issue 1, Pages (July 2003)

Volume 79, Issue 3, Pages (February 2011)

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Volume 78, Issue 8, Pages (October 2010)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Volume 68, Issue 1, Pages (July 2005)

A man with a hole in his penis

Volume 87, Issue 5, Pages (May 2015)

Hemoglobin variability in epoetin-treated hemodialysis patients

Volume 63, Issue 6, Pages (June 2003)

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Current status of maintenance hemodialysis in Beijing, China

Organ transplantation goes to the movies

Volume 61, Issue 1, Pages (January 2002)

The Danish Renal Biopsy Register

Clinical and biochemical correlates of starting “daily” hemodialysis

Volume 80, Issue 10, Pages (November 2011)

Volume 60, Issue 6, Pages (December 2001)

Volume 59, Issue 6, Pages (June 2001)

Rebecca D. Chason, Joan S. Reisch, PhD, Don C. Rockey, MD

Importance of blood pressure control in hemodialysis patient survival

Volume 70, Issue 5, Pages (September 2006)

Volume 77, Issue 12, Pages (June 2010)

The International Pediatric Peritonitis Registry: Starting to walk

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Volume 69, Issue 7, Pages (April 2006)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Letter from W. Lornoy; I. Becaus; J.M. Billiouw and L. Sierens

Characteristics of sudden death in hemodialysis patients

Presentation transcript:

Volume 65, Issue 6, Pages 2419-2425 (June 2004) Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription George R. Bailie, Nancy A. Mason, Jennifer L. Bragg-Gresham, Brenda W. Gillespie, Eric W. Young Kidney International Volume 65, Issue 6, Pages 2419-2425 (June 2004) DOI: 10.1111/j.1523-1755.2004.00658.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Prevalence of analgesic prescription over time. For the individual analgesic categories, patients taking more than one type of analgesic are counted in each. Abbreviations are: COX-2, cyclooxygenase-2; NSAIDs, nonsteroidal anti-inflammatory drugs. Kidney International 2004 65, 2419-2425DOI: (10.1111/j.1523-1755.2004.00658.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Duration of analgesic prescription. Abbreviations are: COX-2, cyclooxygenase-2; NSAIDs, nonsteroidal anti-inflammatory drugs. Kidney International 2004 65, 2419-2425DOI: (10.1111/j.1523-1755.2004.00658.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Facility variation in analgesic use (based on data from September 2000). The boxes extend from the 25th to the 75th percentile, with the horizontal line showing the median percentage of patients on analgesics within facilities. The whiskers extend to the 5th and 95th percentiles. Observed facility variation was significantly (P < 0.0001) greater than one would expect by chance. Kidney International 2004 65, 2419-2425DOI: (10.1111/j.1523-1755.2004.00658.x) Copyright © 2004 International Society of Nephrology Terms and Conditions